COMMUNIQUÉS West-GlobeNewswire

Press release: Terveystalo continues to grow its footprint in well-being services: Kajaanin OMT-Fysioterapia Oy to become part of Terveystalo
01/04/2019
Terveystalo is acquiring Kajaanin OMT-Fysioterapia Oy as at 29 March 2019. The company’s employees will be transferred to Terveystalo as old employees and the operations will continue on the same premises as before in [...]
Neovacs announces an agreement with Biosyn GmbH to diversify its supply of Keyhole Limpet Hemocyanin (KLH)
01/04/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES AN AGREEMENT WITH BIOSYN GmbH TO DIVERSIFY ITS SUPPLY OF KEYHOLE LIMPET HEMOCYANIN (KLH ) Paris et Boston, april 1 st 2019 - 07h30 CEST - Neovacs (Euronext [...]
Néovacs annonce un accord avec Biosyn GmbH afin de diversifier son approvisionnement en Keyhole Limpet Hemocyanin (KLH)
01/04/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE N É OVACS ANNONCE UN ACCORD AVEC BIOSYN GmbH AFIN DE DIVERSIFIER SON APPROVISIONNEMENT EN KEYHOLE LIMPET HEMOCYANIN (KLH) Paris et Boston, le 1 er avril [...]
Novartis adds clinical and preclinical anti-inflammatory programs to portfolio with acquisition of IFM Tre
01/04/2019
Acquisition will give Novartis one clinical and two preclinical programs targeting the NLRP3 inflammasome, a key component of the innate immune system Selective inhibition of the NLRP3 inflammasome is a potentially [...]
ObsEva SA to Participate in Upcoming Investor Conferences
01/04/2019
Geneva, Switzerland and Boston, MA – April 1, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Innate Pharma highlights next generation of cancer immunotherapies at the American Association of Cancer Research (AACR) 2019 annual meeting
01/04/2019
INNATE PHARMA HIGHLIGHTS NEXT GENERATION OF CANCER IMMUNOTHERAPIES AT THE AMERICAN ASSOCIATION OF CANCER RESEARCH (AACR) 2019 ANNUAL MEETING New preclinical data highlights IPH5201 (anti-CD39) and IHP5301 (anti-CD73) [...]
Innate Pharma à l’AACR 2019 : nouvelles données sur la prochaine génération d’immunothérapies des cancers
01/04/2019
INNATE PHARMA A L’AACR 2019 : NOUVELLES DONNÉES SUR LA PROCHAINE GÉNÉRATION D’IMMUNOTHÉRAPIES DES CANCERS Nouvelles données précliniques sur IPH5201 (anti-CD39) et IPH5301 (anti-CD73) ciblant la voie adénosine Premières [...]
Publication of the annual report and invitation to the annual shareholders' meeting
31/03/2019
Nomination of Mr. Peter Guenter for Galapagos' board of directors Mechelen, Belgium; 29 March 2019, 22.15 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) published its annual report for the [...]
Neon Therapeutics Presents Updated Data from Ongoing Phase 1b NT-001 Clinical Trial of Personal Neoantigen Vaccine NEO-PV-01 at AACR 2019 Annual Meeting
31/03/2019
Post-Vaccine Immune and Pathologic Markers Associated with Durable Clinical Benefit in Metastatic Melanoma Patient Cohort Top-line Results, Including 52-Week Clinical Outcomes, from Full NT-001 Trial in Melanoma, Non- [...]
Imvax Announces Positive Results from Clinical Trial of Novel IGV-001 Autologous Cell Vaccine in Treating Patients with Newly Diagnosed Glioblastoma
31/03/2019
Median overall survival was 21.9 months for highest vaccine dose vs. 14.6 months i n published standard of care studies Median progression-free survival was 10.4 months vs. 6.9 and 5.4 months in published standard of [...]
Atara Biotherapeutics Announces Collaborator Presentation of Positive Phase 1 Clinical Results for a Mesothelin-Targeted CAR T Immunotherapy in Patients with Advanced Mesothelioma
31/03/2019
Memorial Sloan Kettering Cancer Center collaborators presented results that a regionally delivered mesothelin-targeted, autologous CAR T was well-tolerated and showed encouraging anti-tumor activity in combination with [...]
Novelion Therapeutics Observes World Lipodystrophy Day
31/03/2019
VANCOUVER, British Columbia and CAMBRIDGE, Mass., March 31, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals [...]
Bio-on board of directors approves Draft Budget and IAS/IFRS Consolidated Financial Statement at 31 December 2018
30/03/2019
Consolidated revenues of 51 million Euro at 31 December 2018 compared to 11 million Euro at 31 December 2017; EBITDA of 42 million Euro at 31 December 2018 compared to 7 million Euro at 31 December 2017; EBIT of 40 [...]
Canada House Wellness Group Reports Third Quarter Fiscal Year 2019 Results
30/03/2019
49% Increase in Revenue Compared to the Same Period in the Prior Year NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 29, 2019 (GLOBE NEWSWIRE) -- Canada House [...]
MedMira Reports Second Quarter Results
30/03/2019
HALIFAX, Nova Scotia, March 29, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended January 31, 2019. Q2 FY2019 Financial Results Highlights Profit [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29/03/2019
CAMBRIDGE, Mass., March 29, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on March 29, 2019, that were previously [...]
Pacific Health Care Organization, Inc. Reports its 2018 Year-End Financial Results
29/03/2019
Newport Beach, CA, March 29, 2019 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its annual report on [...]
Vascepa® Granted Priority Review Status from Health Canada
29/03/2019
New Drug Submission (NDS) for Vascepa in Canada Anticipated to Be Filed in April 2019 by HLS Therapeutics, Under Agreement with Amarin BEDMINSTER, N.J., and DUBLIN, Ireland, March 29, 2019 (GLOBE NEWSWIRE) -- Amarin [...]
Synergy CHC Corp. Announces Fiscal 2018 Year End Results
29/03/2019
Westbrook, Maine, March 29, 2019 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the fiscal year ended December [...]

Pages